Biomea Fusion, Inc.

US$0.57As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BMEAHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (45.94%)
Div yield —
ROE (164.14%)
Biotechnology
Beta (5Y) (0.14)
PE TTM —
TSR TTM (58.32%)
Mkt cap US$41.08M
ROIC (146.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.641
13.01%
115.30%
Hold 5|1|12|8|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
0.01
(2.05%)
6.10%
0.42%
13.26%
Revenue$M
3.230
3.331
3.373
3.275
11.09%
8.85%
11.06%
4.57%
Peers (US$41.08M)
Cap (US$)
PE
41.72M
—
41.60M
—
40.84M
—
40.99M
—
Capital
TTM
5Y
10Y
Leveragex
1.803
1.534
1.324
EBIT/Intx
0.995
0.254
0.197
Own earn%
11.08
(8.97)
(24.56)
Sh yield%
22.83
43.29
37.71
Owners
Insiders/Inst%
8.42
54.12
Short interest%
5.73
SBC / revenue%
4.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
0–4
$1 testx
0.3
Incr. ROIC%
3